| 1211 |
1146: premature, Spawning |
1164: Increased, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1222 |
1146: premature, Spawning |
1141: Decreased, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1179 |
1144: premature, spawning 1 |
1141: Decreased, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 3708 |
2400: Preputial epithelial morphogenesis, disrupted |
2401: Male PPS, failed/delayed |
Dec 16, 2025 |
Dec 16, 2025 |
1 AOP
|
| 1283 |
1234: Production of nerve growth factor , Epithelial irritation |
1222: SP (Substance P) release, Local increase of SP |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1358 |
1274: Production of α-smooth muscle actin |
1276: Lung fibrosis |
Feb 15, 2017 |
Feb 15, 2017 |
None
|
| 93 |
77: Production, Critical Metabolites (CGA 330050 and CGA 265307) |
164: Induction, Liver “Dysfunctional” Changes by CGA 330050 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 332 |
302: Production, VEGF-A |
301: Binding, VEGF-A |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 333 |
302: Production, VEGF-A |
304: Decreased, VegfR2 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 69 |
57: Proliferation, Cell proliferation in the absence of cytotoxicity |
142: Hyperplasia, Hyperplasia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1105 |
1067: Proliferation/Clonal Expansion, aberrant basal-type cells |
1068: Endometrial squamous metaplasia, Increase |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1082 |
1042: Proliferation/Clonal Expansion, smooth muscle |
1043: Hypertrophy/hyperplasia, smooth muscle |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2540 |
1961: Prolongation of Action Potential |
1962: Prolongation of QT interval |
Dec 13, 2021 |
Dec 13, 2021 |
2 AOPs
|
| 3411 |
1961: Prolongation of Action Potential |
2283: Early premature depolarizations |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 2541 |
1962: Prolongation of QT interval |
1963: Torsades de Pointes |
Dec 13, 2021 |
Dec 13, 2021 |
2 AOPs
|
| 2853 |
1962: Prolongation of QT interval |
1106: Occurrence, cardiac arrhythmia |
Jan 29, 2023 |
Jan 29, 2023 |
None
|
| 3420 |
1962: Prolongation of QT interval |
2283: Early premature depolarizations |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 2429 |
1842: TLR9 activation |
1897: MyD88 activation |
Jul 8, 2021 |
Jul 8, 2021 |
1 AOP
|
| 2433 |
1842: TLR9 activation |
1895: inflammasome activity, increased |
Jul 8, 2021 |
Jul 8, 2021 |
1 AOP
|
| 604 |
599: prolonged, Depolarization of neuronal membrane |
600: Overactivation, Neuronotransmitter release |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1098 |
1061: prolonged, elevation of serun CCK |
1062: Increased, Cellular proliferation / hyperplasia of acinar cells |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1111 |
1075: prolonged, estrus cycle |
1076: Increased, circulating estrogen levels |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1112 |
1075: prolonged, estrus cycle |
1077: Increased, prolactin exposure |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2829 |
1053: Promotion, ovarian adenomas |
2092: Promotion, Ovarian Cancer |
Jan 13, 2023 |
Mar 11, 2023 |
1 AOP
|
| 2830 |
1054: Promotion, ovarian granular cell tumors |
2092: Promotion, Ovarian Cancer |
Jan 13, 2023 |
Jan 13, 2023 |
None
|